Loading clinical trials...
Loading clinical trials...
This is a 48 week study that is intended for HIV Infected persons whose first treatment regimen was with a nonnucleoside reverse transcriptase inhibitor (NNRTI) and who are now failing that regimen. T...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Pfizer
NCT06598397 · Human Immunodeficiency Virus (HIV), Smoking Cessation
NCT07071623 · Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis
NCT07115901 · HIV (Human Immunodeficiency Virus)
NCT07236905 · HIV (Human Immunodeficiency Virus)
NCT04375800 · Human Immunodeficiency Virus (HIV) Infection
Pfizer Investigational Site
Beverly Hills, California
Pfizer Investigational Site
Long Beach, California
Pfizer Investigational Site
Newport Beach, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions